Insights

Specialized Niche Focus MOD3 Pharma's expertise in Orally Inhaled and Nasal Drug Products positions it as a targeted solution provider for early-phase clinical trials, making it an attractive partner for biotech and pharmaceutical firms seeking specialized manufacturing services.

Growth Potential With a revenue range of 1 million to 10 million and support for Phase 1 and 2 trials, MOD3 Pharma presents opportunities for expansion as its clients progress through clinical development stages, increasing demand for its inhalation and nasal product manufacturing.

Technology Capabilities Utilizing advanced manufacturing techniques such as spray drying and semi-automated filling, MOD3 Pharma offers innovative solutions that can meet the evolving needs of clients focused on quality and efficiency, creating potential upsell opportunities.

Partnership Expansion Given its focus on mitigating risk, delay, and cost for investigational drugs, MOD3 Pharma can benefit from strategic partnerships with larger CROs or pharma companies seeking reliable early-stage manufacturing support for inhaled and nasal therapies.

Market Positioning As a smaller but highly specialized firm operating within a niche market, MOD3 Pharma is well-positioned to attract clients looking for dedicated expertise in inhaled and nasal drug development, offering potential for long-term client relationships and referral growth.

MOD3 Pharma Tech Stack

MOD3 Pharma uses 8 technology products and services including Smart Slider 3, Google Sign-in, Google Maps, and more. Explore MOD3 Pharma's tech stack below.

  • Smart Slider 3
    Design
  • Google Sign-in
    Identity Verification
  • Google Maps
    Maps
  • Priority Hints
    Performance
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • reCAPTCHA
    Security
  • Apache
    Web Servers

Media & News

MOD3 Pharma's Email Address Formats

MOD3 Pharma uses at least 2 format(s):
MOD3 Pharma Email FormatsExamplePercentage
FLast@enterisbiopharma.comJDoe@enterisbiopharma.com
86%
First.Last@enterisbiopharma.comJohn.Doe@enterisbiopharma.com
6%
Last@enterisbiopharma.comDoe@enterisbiopharma.com
5%
F.Last@enterisbiopharma.comJ.Doe@enterisbiopharma.com
3%

Frequently Asked Questions

What is MOD3 Pharma's phone number?

Minus sign iconPlus sign icon
You can contact MOD3 Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MOD3 Pharma's official website and social media links?

Minus sign iconPlus sign icon
MOD3 Pharma's official website is mod3pharma.com and has social profiles on LinkedIn.

What is MOD3 Pharma's NAICS code?

Minus sign iconPlus sign icon
MOD3 Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does MOD3 Pharma have currently?

Minus sign iconPlus sign icon
As of December 2025, MOD3 Pharma has approximately 13 employees across 2 continents, including North AmericaEurope. Key team members include Vice President Business Development: T. S.Vice President Business Development: T. S.Vice President, Product Development & Quality Control: T. D.. Explore MOD3 Pharma's employee directory with LeadIQ.

What industry does MOD3 Pharma belong to?

Minus sign iconPlus sign icon
MOD3 Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does MOD3 Pharma use?

Minus sign iconPlus sign icon
MOD3 Pharma's tech stack includes Smart Slider 3Google Sign-inGoogle MapsPriority HintsPHPYoast SEOreCAPTCHAApache.

What is MOD3 Pharma's email format?

Minus sign iconPlus sign icon
MOD3 Pharma's email format typically follows the pattern of FLast@enterisbiopharma.com. Find more MOD3 Pharma email formats with LeadIQ.

When was MOD3 Pharma founded?

Minus sign iconPlus sign icon
MOD3 Pharma was founded in 2013.

MOD3 Pharma

Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees

MOD3 Pharma combines decades of CMC experience with a laser focus on Orally Inhaled and Nasal Drug Products (OINDP) to transform your investigational drug into a clinic ready product.

Using a stage appropriate methodology within the Module 3 framework, our experts work with you to manage risk, mitigate delay and reduce cost while ensuring your OINDP product's quality, safety, and efficacy.

Risk. Time. Cost. The trifecta of challenges that can keep you awake at night. Because your project matters – it really matters, not just to you, but to the patients that will rely on your therapy to make their lives better.

Specifically supporting clients working within phases 1&2 of clinical trials, MOD3 Pharma’s capabilities include spray drying, semi-automated filling and assembly for single dose powder and liquid nasal systems, bi-dose and multidose nasal devices. This service proposition uniquely fills the gap for organizations needing early phase clinical supplies.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2013
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    MOD3 Pharma's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    MOD3 Pharma's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.